Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Calimmune
10990 Wilshire Blvd.
Los Angeles, CA 90024
Phone: 310-806-6240
http://calimmune.com/

Calimmune Inc. is a clinical-stage biotechnology company focused on developing novel gene therapies that have the potential to improve and protect the lives of patients by enhancing their immune systems. The company was founded in 2006 from technology developed in the labs of Nobel Laureate David Baltimore, Ph.D. (California Institute of Technology), Irvin Chen, Ph.D. (University of California, Los Angeles) and Inder M. Verma, Ph.D. (Salk Institute for Biological Studies). Calimmune's lead product candidate for HIV, now in Phase I/II studies, is being evaluated as a one-time treatment to prevent HIV progression to AIDS. Calimmune is developing a full product pipeline of therapeutic candidates to address the unique needs of individuals at different stages of HIV infection and with various treatment histories. The company is headquartered in Tucson, Arizona with labs and branch offices in Pasadena, California and Sydney, Australia.

Key Contact
NameTitleE-Mail
Louis BretonCEO


Funding Events
DateAmountTypeInvestors
05/27/15$15,000,000Series B Alexandria Real Estate Equities
RA Capital
Translational Accelerator
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.